These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 26546479)
1. Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. Ishii M; Iadecola C Biochim Biophys Acta; 2016 May; 1862(5):966-74. PubMed ID: 26546479 [TBL] [Abstract][Full Text] [Related]
2. The role of insulin in the vascular contributions to age-related dementia. Hughes TM; Craft S Biochim Biophys Acta; 2016 May; 1862(5):983-91. PubMed ID: 26657615 [TBL] [Abstract][Full Text] [Related]
3. Clinical-pathologic correlations in vascular cognitive impairment and dementia. Flanagan M; Larson EB; Latimer CS; Cholerton B; Crane PK; Montine KS; White LR; Keene CD; Montine TJ Biochim Biophys Acta; 2016 May; 1862(5):945-51. PubMed ID: 26319420 [TBL] [Abstract][Full Text] [Related]
4. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Helman AM; Murphy MP Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178 [TBL] [Abstract][Full Text] [Related]
5. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons. Kapasi A; Schneider JA Biochim Biophys Acta; 2016 May; 1862(5):878-86. PubMed ID: 26769363 [TBL] [Abstract][Full Text] [Related]
6. Adiposity hormones and dementia. Gustafson DR J Neurol Sci; 2010 Dec; 299(1-2):30-4. PubMed ID: 20875649 [TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome. Wilcock DM; Schmitt FA; Head E Biochim Biophys Acta; 2016 May; 1862(5):909-14. PubMed ID: 26593849 [TBL] [Abstract][Full Text] [Related]
13. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. Galvan V; Hart MJ Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition. Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction. Henry-Feugeas MC Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499 [TBL] [Abstract][Full Text] [Related]
16. Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. McGuire MJ; Ishii M Cell Mol Neurobiol; 2016 Mar; 36(2):203-17. PubMed ID: 26993509 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of vascular damage in dementia. Biessels GJ Biochim Biophys Acta; 2016 May; 1862(5):869-77. PubMed ID: 26612719 [TBL] [Abstract][Full Text] [Related]
18. Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment. Banerjee G; Wilson D; Jäger HR; Werring DJ Biochim Biophys Acta; 2016 May; 1862(5):926-38. PubMed ID: 26687324 [TBL] [Abstract][Full Text] [Related]
19. Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years. Gilbert T; Roche S; Blond E; Bar JY; Drai J; Cuerq C; Haution-Bitker M; Ecochard R; Bonnefoy M J Alzheimers Dis; 2018; 66(3):1255-1264. PubMed ID: 30400097 [TBL] [Abstract][Full Text] [Related]
20. The epidemiology of adiposity and dementia. Whitmer RA Curr Alzheimer Res; 2007 Apr; 4(2):117-22. PubMed ID: 17430233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]